HV
☆    

India,
2010-04-14 20:37
(5919 d 05:28 ago)

Posting: # 5136
Views: 3,932
 

 Truncated approach for NTI? [Design Issues]

Dear all,

There are a few narrow therapeutic index drugs with prolonged elimination half-life e.g. warfarin, tacrolimus, etc. These are the drugs for which usually tightended interval (90-111.11% for EU and 90-112% for HPFB) is applicable for AUC.
Is it possible to apply truncated approach (sampling till 72 hrs) for these molecules?

Thanks,
Heema Valera
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2010-04-14 20:48
(5919 d 05:18 ago)

@ HV
Posting: # 5137
Views: 3,232
 

 Why not?

Dear Heema,

Why do you think that it is not possible?

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
HV
☆    

India,
2010-04-14 21:19
(5919 d 04:47 ago)

@ Helmut
Posting: # 5139
Views: 3,199
 

 Why not?

❝ Why do you think that it is not possible?


Dear Helmut,
thanks for prompt response!
i think so, because overall extent of absorption is of importance for such NTIs. And the truncated approach repesents only a fraction of total extent. Will you please share your thoughts on application of truncted area (AUC72) for NTIs as well?

Thanks,

Heema
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2010-04-14 21:38
(5919 d 04:28 ago)

@ HV
Posting: # 5141
Views: 3,179
 

 Absorption important

Dear Heema,

❝ [...] overall extent of absorption is of importance for such NTIs.


No, in BE we are interested in the difference of absorption between formulations. Elimination is specific for the drug. After 2-4× tmax the AUC-ratio does not change any more, only variability increases (just saw Kamal Midha walking 'round the corner ;-)). In other words AUC72(T)/AUC72(R) ~ AUC504(T)/AUC504(R) ~ AUCinf(T)/AUCinf(R), but AUC's CVintra,72<CVintra,504<CVintra,inf. Please search the forum for examples and references.

Above said is only true for immediate relase formulations (elimination = slowest phase). For some MR formulations (CR, but not DR) the slowest phase is absorption - the one we are interested in: in such a case truncation does not make sense. Luckily there are only a few stupid controlled release formulations of drug with a long half-life on the market.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
288 visitors (0 registered, 288 guests [including 18 identified bots]).
Forum time: 02:06 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5